Abstract

Chronic kidney disease (CKD) is characterized by structural abnormalities and the progressive loss of kidney function. Extracellular vesicles (EVs) from human umbilical cord tissue (hUCT)-derived mesenchymal stem cells (MSCs) and expanded human umbilical cord blood (hUCB)-derived CD133+ cells (eCD133+) maintain the characteristics of the parent cells, providing a new form of cell-free treatment. We evaluated the effects of EVs from hUCT-derived MSCs and hUCB-derived CD133+ cells on rats with CDK induced by an adenine-enriched diet. EVs were isolated by ultracentrifugation and characterized by nanoparticle tracking analysis (NTA) and electron microscopy. The animals were randomized and divided into the MSC-EV group, eEPC-EV group and control group. Infusions occurred on the seventh and 14th days after CKD induction. Evaluations of kidney function were carried out by biochemical and histological analyses. Intense labeling of the α-SMA protein was observed when comparing the control with MSC-EVs. In both groups treated with EVs, a significant increase in serum albumin was observed, and the increase in cystatin C was inhibited. The results indicated improvements in renal function in CKD, demonstrating the therapeutic potential of EVs derived from MSCs and eCD133+ cells and suggesting the possibility that in the future, more than one type of EV will be used concurrently.

Highlights

  • We evaluated the effects of extracellular vesicles (EVs) from human umbilical cord tissue-derived mesenchymal stem cells (MSCs) and expanded human umbilical cord blood-derived CD133+

  • Immunophenotypic characterization of CD133+ cells was performed after expansion and showed low expression levels of CD133 and CD 34 compared to the immunophenotypic profile of purified CD133+ (Figure 2b)

  • We observed a significant increase in α-smooth muscle actin (α-SMA) expression in the control group compared to the MSC-EV group

Read more

Summary

A Comparative Preclinical Analysis

Dayane Mayumi Miyasaki 1,2, Alexandra Cristina Senegaglia 1,2 , Sérgio Adriane Bezerra de Moura 3 , Amanda Leitolis 2,4 , Luiz Guilherme Achcar Capriglione 1,2, Letícia Fracaro 1,2 , Lidiane Maria Boldrini Leite 1,2 , Paulo Henrique Utumi 1,2 , Felipe Yukio Ishikawa Fragoso 1,2 , Fernando Meyer 1 , Alejandro Correa 2,4,*,†.

Introduction
Cell Expansion and Characterization
Isolation and Characterization Extracellular Vesicles
The Animal Model Showed the Characteristics of CKD
Treatment with EVs and Biochemical Analyses
Histopathological
Discussion
Materials and Methods
Isolation and Expansion of MSCs
Isolation of Extracellular Vesicles
Biochemical Analysis
Histopathological Analysis
Immunohistochemistry
Statistical Analysis

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.